Publications

Found 292 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Doron I, Kusakabe T, Iliev ID.  2023.  Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity.. Semin Immunol. 67:101757.
Doron I, Leonardi I, Li XV, Fiers WD, Semon A, Bialt-DeCelie M, Migaud M, Gao IH, Lin W-Y, Kusakabe T et al..  2021.  Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies.. Cell.
Doron I, Mesko M, Li XV, Kusakabe T, Leonardi I, Shaw DG, Fiers WD, Lin W-Y, Bialt-DeCelie M, Román E et al..  2021.  Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn's disease.. Nat Microbiol. 6(12):1493-1504.
Doron I, Leonardi I, Iliev ID.  2019.  Profound mycobiome differences between segregated mouse colonies do not influence Th17 responses to a newly introduced gut fungal commensal.. Fungal Genet Biol. 127:45-49.
E
Emanuel E, Arifuzzaman M, Artis D.  2024.  Epithelial-neuronal-immune cell interactions: Implications for immunity, inflammation, and tissue homeostasis at mucosal sites.. J Allergy Clin Immunol. 153(5):1169-1180.
F
Fernandez-Ruiz D, Ng WYi, Holz LE, Ma JZ, Zaid A, Wong YChun, Lau LShong, Mollard V, Cozijnsen A, Collins N et al..  2016.  Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection.. Immunity. 45(4):889-902.
Fiers WD, Gao IH, Iliev ID.  2019.  Gut mycobiota under scrutiny: fungal symbionts or environmental transients? Curr Opin Microbiol. 50:79-86.
Fiers WD, Leonardi I, Iliev ID.  2020.  From Birth and Throughout Life: Fungal Microbiota in Nutrition and Metabolic Health.. Annu Rev Nutr.
Flamar A-L, Klose CSN, Moeller JB, Mahlakõiv T, Bessman NJ, Zhang W, Moriyama S, Stokic-Trtica V, Rankin LC, Putzel GGarbès et al..  2020.  Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.. Immunity.
Frey MK, Kahn RM, Chapman-Davis E, Tubito F, Pires M, Christos P, Anderson S, Mukherjee S, Jordan B, Blank SV et al..  2020.  Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.. J Clin Oncol. :JCO1902005.
Fung TC, Bessman NJ, Hepworth MR, Kumar N, Shibata N, Kobuley D, Wang K, Ziegler CGK, Goc J, Shima T et al..  2016.  Lymphoid-Tissue-Resident Commensal Bacteria Promote Members of the IL-10 Cytokine Family to Establish Mutualism.. Immunity. 44(3):634-46.
Fung TC, Artis D, Sonnenberg GF.  2014.  Anatomical localization of commensal bacteria in immune cell homeostasis and disease.. Immunol Rev. 260(1):35-49.
G
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Galloway-Peña J, Iliev ID, McAllister F.  2024.  Fungi in cancer.. Nat Rev Cancer. 24(5):295-298.
Garaude J, Kent A, van Rooijen N, J Blander M.  2012.  Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses.. Sci Transl Med. 4(120):120ra16.
Giacomin PR, Moy RH, Noti M, Osborne LC, Siracusa MC, Alenghat T, Liu B, McCorkell KA, Troy AE, Rak GD et al..  2015.  Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity.. J Exp Med. 212(10):1513-28.
Gillen DL, Meyskens FL, Morgan TR, Zell JA, Carroll R, Benya R, Chen W-P, Mo A, Tucker C, Bhattacharya A et al..  2015.  A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.. Cancer Prev Res (Phila). 8(3):222-30.
Glynn S, Lipkin S, Zhang T, Sboner A, Elemento O, Van Besien K, Beltran H.  2019.  The application of precision medicine in diagnosing familial Mediterranean fever.. Leuk Lymphoma. 60(8):2091-2093.
Goc J, Hepworth MR, Sonnenberg GF.  2016.  Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer.. Int Immunol. 28(1):43-52.
Goc J, Lv M, Bessman NJ, Flamar A-L, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR et al..  2021.  Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.. Cell. 184(19):5015-5030.e16.
Goettel JA, Kotlarz D, Emani R, Canavan JB, Konnikova L, Illig D, Frei SM, Field M, Kowalik M, Peng K et al..  2019.  Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model.. Cell Mol Gastroenterol Hepatol.
Gogokhia L, Buhrke K, Bell R, Hoffman B, D Brown G, Hanke-Gogokhia C, Ajami NJ, Wong MC, Ghazaryan A, Valentine JF et al..  2019.  Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.. Cell Host Microbe. 25(2):285-299.e8.
Göktuna SI, Canli O, Bollrath J, Fingerle AA, Horst D, Diamanti MA, Pallangyo C, Bennecke M, Nebelsiek T, Mankan AK et al..  2022.  IKKα Promotes Intestinal Tumorigenesis by Limiting Recruitment of M1-like Polarized Myeloid Cells.. Cell Rep. 38(9):110471.
Goodenberger MKL, Thomas BC, Riegert-Johnson D, C Boland R, Plon SE, Clendenning M, Win AKo, Senter L, Lipkin SM, Stadler ZK et al..  2016.  PMS2 monoallelic mutation carriers: the known unknown.. Genet Med. 18(1):13-9.
Grigg JB, Sonnenberg GF.  2017.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.. J Immunol. 198(2):564-571.